[EN] TETRAHYDROPYRAZOLOPYRIMIDINE COMPOUNDS<br/>[FR] COMPOSÉS TÉTRAHYDROPYRAZOLOPYRIMIDINES
申请人:EISAI R&D MAN CO LTD
公开号:WO2013181579A2
公开(公告)日:2013-12-05
Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis